
Novartis has announced that the President of its oncology business, Bruno Strigini, is to retire next year, citing personal reasons …

Novartis has hired Merck’s president of Europe and Canada Bruno Strigini to be its president of oncology. The role was …
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer

